Literature DB >> 21325068

Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations.

Hiroshi Saeki1, Hiroyuki Kitao, Keiji Yoshinaga, Tomonori Nakanoko, Nobuhide Kubo, Yoshihiro Kakeji, Masaru Morita, Yoshihiko Maehara.   

Abstract

PURPOSE: LOH at the p53 locus has been reported to be associated with esophageal squamous cell carcinogenesis. The aim of this study is to identify potential mechanisms resulting in LOH around the p53 locus in its carcinogenesis. EXPERIMENTAL
DESIGN: We investigated 10 esophageal cancer cell lines and 91 surgically resected specimens, examining them for LOH at the p53 locus on chromosome 17. We examined the p53 gene by using microsatellite analysis, comparative genomic hybridization (CGH), FISH, and single-nucleotide polymorphism-CGH (SNP-CGH).
RESULTS: In an analysis of specimens by microsatellite markers, a close positive correlation was found between p53 mutations and LOH at the p53 locus (P < 0.01). Although four cell lines were found to be homozygous for p53 mutations, LOH at the p53 locus was not detected by CGH. Among two p53 mutant cancer cell lines and five p53 mutant/LOH cancer specimens analyzed by FISH, both the cell lines and four of the specimens exhibited no obvious copy number loss at the p53 locus. SNP-CGH analysis, which allows both determination of DNA copy number and detection of copy-neutral LOH, showed that LOHs without copy number change were caused by whole or large chromosomal alteration.
CONCLUSIONS: LOH without copy number change at the p53 locus was observed in p53 mutant esophageal squamous cell carcinomas. Our data suggest that copy-neutral LOH occurring as a result of chromosomal instability might be the major mechanism for inactivation of the intact allele in esophageal squamous cell carcinogenesis associated with p53 mutation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325068     DOI: 10.1158/1078-0432.CCR-10-1996

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  20 in total

Review 1.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

2.  Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.

Authors:  Gouri Sankar Sen; Suchismita Mohanty; Dewan Md Sakib Hossain; Sankar Bhattacharyya; Shuvomoy Banerjee; Juni Chakraborty; Shilpi Saha; Pallab Ray; Pushpak Bhattacharjee; Debaprasad Mandal; Arindam Bhattacharya; Samit Chattopadhyay; Tanya Das; Gaurisankar Sa
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

Review 3.  Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Hiroshi Saeki; Yuichiro Nakashima; Yoko Zaitsu; Yasuo Tsuda; Yuta Kasagi; Koji Ando; Yu Imamura; Kippei Ohgaki; Shuhei Ito; Yasue Kimura; Akinori Egashira; Eiji Oki; Masaru Morita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2015-03-05       Impact factor: 2.549

4.  p53 phosphorylation and TP53 copy-number alterations in chronic graft-versus-host oral lichen preceding squamous cell carcinoma.

Authors:  Maxime Battistella; Wendy Cuccuini; Morad Elbouchtaoui; Christophe Leboeuf; Louis-François Plassa; Fatiha Bouhidel; Arnaud Rigolet; Véronique Meignin; Gérard Socié; Philippe Ratajczak; Anne Janin
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

5.  Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.

Authors:  M Kano; K Matsushita; B Rahmutulla; S Yamada; H Shimada; S Kubo; T Hiwasa; H Matsubara; F Nomura
Journal:  Gene Ther       Date:  2015-08-04       Impact factor: 5.250

Review 6.  Analysis of TP53 mutation status in human cancer cell lines: a reassessment.

Authors:  Bernard Leroy; Luc Girard; Antoinette Hollestelle; John D Minna; Adi F Gazdar; Thierry Soussi
Journal:  Hum Mutat       Date:  2014-05-06       Impact factor: 4.878

7.  Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.

Authors:  Neha Parikh; Susan Hilsenbeck; Chad J Creighton; Tajhal Dayaram; Ryan Shuck; Eve Shinbrot; Liu Xi; Richard A Gibbs; David A Wheeler; Lawrence A Donehower
Journal:  J Pathol       Date:  2014-01-29       Impact factor: 7.996

8.  Early Gastric Cancer: identification of molecular markers able to distinguish submucosa-penetrating lesions with different prognosis.

Authors:  Paola Ulivi; Luca Saragoni; Chiara Molinari; Gianluca Tedaldi; Francesca Rebuzzi; Paolo Morgagni; Laura Capelli; Sara Ravaioli; Maria Maddalena Tumedei; Emanuela Scarpi; Anna Tomezzoli; Riccardo Bernasconi; Maria Raffaella Ambrosio; Alessia D'Ignazio; Leonardo Solaini; Francesco Limarzi; Giorgio Ercolani; Giovanni Martinelli
Journal:  Gastric Cancer       Date:  2020-11-06       Impact factor: 7.370

Review 9.  Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?

Authors:  J Morscio; D Dierickx; T Tousseyn
Journal:  Clin Dev Immunol       Date:  2013-04-14

10.  Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.

Authors:  Yadav Sapkota; Sunita Ghosh; Raymond Lai; Bradley P Coe; Carol E Cass; Yutaka Yasui; John R Mackey; Sambasivarao Damaraju
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.